Literature DB >> 23619214

Sustained-release ganciclovir implant as prophylaxis for cytomegalovirus retinitis in a child undergoing bone marrow transplantation.

I B Wong, S C Teoh, A E Yeoh, G Lingam.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23619214      PMCID： PMC3709400          DOI： 10.1038/eye.2013.81

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  4 in total

1.  Intravitreal sustained-release ganciclovir implants for severe bilateral cytomegalovirus retinitis after stem cell transplantation.

Authors:  Fredrik Ghosh; Lars-Jörgen Hansson; Gunnel Bynke; Albert N Békássy
Journal:  Acta Ophthalmol Scand       Date:  2002-02

2.  Clinical outcomes in patients with cytomegalovirus retinitis treated with ganciclovir implant.

Authors:  Kathleen C Oktavec; Kisten Nolan; Diane M Brown; James P Dunn; Alison G Livingston; Jennifer E Thorne
Journal:  Am J Ophthalmol       Date:  2012-01-20       Impact factor: 5.258

3.  Use of the ganciclovir implant for treating cytomegalovirus retinitis secondary to immunosuppression after bone marrow transplantation.

Authors:  P F McAuliffe; M J Hall; H Castro-Malaspina; M H Heinemann
Journal:  Am J Ophthalmol       Date:  1997-05       Impact factor: 5.258

4.  Risk factors for cytomegalovirus retinitis in patients with cytomegalovirus viremia after hematopoietic stem cell transplantation.

Authors:  Sohee Jeon; Won Ki Lee; Yongeun Lee; Dong Gun Lee; Jong Wook Lee
Journal:  Ophthalmology       Date:  2012-05-30       Impact factor: 12.079
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.